Sarepta Therapeutics

Sarepta Therapeutics Announces Recipients of LGMD Grant Awards for 2024; Program Supports Early Genetic Testing and Awareness

Recipients awarded a total of more than $100,000 in grants Funding will support education and activities to shorten diagnostic journey. 30 September 2024 -- Massachusetts, US -- Sarepta Therapeutics, Inc, the leader in precision genetic medicine for rare diseases, today announced it awarded more than $100,000 in grant funding through the Limb-girdle muscular dystrophy (LGMD) Grant Award Program....
Hill House, 1 Little New Street London, EC4A 3TR United Kingdom

617-301-8566